Sinopharm inactivated COVID-19 vaccine BIBP - Interim recommendations and more

These WHO interim recommendations for use of the COVID-19 vaccine BIBP (Sinopharm) were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes. 

More information: